An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting.

Addison M DudaHelena R MaCésar A VillalobosSophia A KuhnKatherine HeSarah R SeayAbigail C JacksonChristine M SuhElena A PuccioDeverick J AndersonVance G FowlerLingchong YouKatherine J Franz

Published in: bioRxiv : the preprint server for biology (2024)

Keyphrases

microbial community
cancer therapy
signaling pathway
drug release
gram negative